Altimmune: Q4 Earnings Insights

Altimmune (NASDAQ:ALT) released its Q4 earnings on Thursday, March 5, 2026 at 07:00 AM.

Here's what's important from the earnings announcement.

Earnings

Altimmune missed estimated earnings by -8.0%, reporting an EPS of $-0.27 versus an estimate of $-0.25.

Revenue was up $21 thousand from the same period last year.

Past Earnings Performance

In the previous quarter, the company beat on EPS by $0.07, resulting in a 4.31% increase change in the share price the following day.

To track all earnings releases for Altimmune visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.